https://www.biospace.com/cellectis-and-cytovia-partner-to-develop-natural-killer-cells
Shares of Cellectis Therapeutics were up nearly 10% in premarket trading after the company forged a deal with Cytovia Therapeutics to develop immunotherapies...
natural killer cellcellectisstockjumpsfollowing
https://pubmed.ncbi.nlm.nih.gov/23277329/
The Fc-engineered CD19 antibody MOR208 (XmAb5574) induces natural killer cell-mediated lysis of acute lymphoblastic leukemia cells from pediatric and adult...
natural killerfcengineeredantibodyinduces
https://www.rcsb.org/structure/6MSS
Diversity in the type II Natural Killer T cell receptor repertoire and antigen specificity leads to differing CD1d docking strategies
rcsb pdbtype iinatural killerdiversity
https://vycellix.com/latest/vycellix-cell-therapy-platforms-featured-at-nk2023-natural-killer-cell-meetings-in-norway/
Proof-of-concept data reported for new multi-antigen engager platform (VY-GAGE) designed to overcome solid tumor defense mechanisms Single-step CD45 allogeneic...
cell therapynatural killerplatformsfeatured
https://www.fiercebiotech.com/biotech/gilead-follows-big-pharma-peers-dragonflys-pond-300m-deal-nk-cell-engagers
Gilead has become the latest Big Pharma to find a gem from Dragonfly Therapeutics, entering a $300 million cancer and inflammatory disease deal.
gileadsignsdealdragonflytherapeutics
https://pubmed.ncbi.nlm.nih.gov/40498022/
Memory is an incredible aspect of our immune system. Similarly to our cognitive memory, it allows us to remember and respond more efficiently to subsequent...
natural killer cellpowermemoryperspective
https://www.dana-farber.org/clinical-trials/20-120
This is an open-label single center Phase 1a/1b study with the primary objective of establishing the safety and exploring the efficacy of infusing the ex vivo...
natural killerphasestudyautologousmemory